4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/MLN4924 [NAE Inhibitor] Solution/AG-CS1-0103-M001/1 mg
商品详细Adipogen/MLN4924 [NAE Inhibitor] Solution/AG-CS1-0103-M001/1 mg
Adipogen/MLN4924 [NAE Inhibitor] Solution/AG-CS1-0103-M001/1 mg
Adipogen/MLN4924 [NAE Inhibitor] Solution/AG-CS1-0103-M001/1 mg
商品编号: AG-CS1-0103-M001
品牌: Adipogen Inc
市场价: ¥4060.00
美元价: 2436.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
More Information
Product Details
Synonyms Pevonedistat; Nedd8 E1 Activating Enzyme Inhibitor
Product Type Chemical
Properties
Formula C21H25N5O4S
MW 443.5
CAS 905579-51-3
Purity Chemicals ≥99% (HPLC)
Appearance Liquid.
Formulation 20mM stock solution in DMSO.
Declaration Manufactured by Boston Biochem
InChi Key MPUQHZXIXSTTDU-QXGSTGNESA-N
Shipping and Handling
Shipping BLUE ICE
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stock solutions are stable for at least 3 months when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Potent, selective and cell-permeable inhibitor of Nedd8 E1 Activating Enzyme (NAE).
  • By inhibiting the Neddylation pathway this molecule disrupts cullin-RING ligase activity, leading to inhibition of proliferation or apoptotic death of various human tumor cells through the deregulation of S-phase DNA synthesis.
  • Angiogenesis inhibitor.
Product References
  1. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer: T.A. Soucy, et al.; Nature 458, 7239 (2009)
  2. MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells: Y. Gu, et al.; Blood 123, 3269 (2014)
  3. NEDD8-activating enzyme inhibitor, MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis through up-regulation of ATF-4: X. Liu, et al.; BBRC 488, 1 (2017)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。